BioCentury
ARTICLE | Company News

Turnstone Biologics cancer news

June 1, 2015 7:00 AM UTC

Turnstone Biologics launched to develop and commercialize oncolytic vaccine immunotherapies using its Marabex technology to treat cancer. The technology is in preclinical development. Founding partner...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article